4LEE S D,KIM H J,HWANG S J,et al.Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine:a case report[J].The Korean J Intern Med,2007,22(2):109-112.
5LIN E,MORRIS J S,AYERS G D.Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumot activity[J].Oncology(Huntingt),2002,16(12):31-37.
6MILANO G,ETIENNE GRIMALDI M C,MARI M,et al.Candidate mechanisms for capecitabine-related hand-foot syndrome[J].Br J Clin Pharmacol,2008,66(1):88-95.
7HONDA J,SASA M,MORIYA T,et al.Thymidine phosphorylase and dihydropyrimidine dehydrogenase are predictive factors of therapeutic efficacy of capecitabine monotherapy for breast cancer-preliminary results[J].J Med Invest,2008,55(1-2):54-60.
8ASGARI M M,HAGGERTY J G,MCNIFFJ M,et al.Expression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumors[J].J Cutan Pathol,1999,26(6):287-294.
9MROZEK ORLOWSKI M E,FRYE D K,SANBORN H M.Capecitabine:nursing implications of a new oral chemotherapeutic agent[J].Oncol Nurs Forum,1999,26(4):753-762.
10HESS V,SALZBERG M,BORNER M,et al.Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma:a phase Ⅰ/Ⅱ trial[J].J Clin Oncol,2003,21(1):66-68.
